Nav: Home

New research shows promise in disabling cancer's defences

March 09, 2017

Recent study out of the University of Ottawa opens door for new disease therapies in cancer, ALS, Fragile X Syndrome and others.

Part of what makes cancer cells so devastating is their ability to fight back against treatments -- sometimes they work, sometimes they don't. But what if we could take away cancer cells' defences altogether?

Researchers from the University of Ottawa have taken an important step forward to doing just that. Dr. Kristin Baetz says the results of a three-way research collaboration could open doors to new therapeutics to treat a variety of diseases, including cancer.

Dr. Baetz is an associate professor at uOttawa's Faculty of Medicine and Director of the Ottawa Institute of Systems Biology. Her lab studies stress granules (SGs), which are structures produced by the body's cells to protect against environmental stressors. Unfortunately, SGs also help cancer cells defend themselves against chemotherapeutic treatments, which can then lead to resistance to the common therapy.

"The first step in figuring out how to prevent this from happening is to understand how stress granules are formed and disassembled," explains Dr. Baetz, "and we now have key information."

Using yeast cells, her lab has identified a class of enzymes that play an active role in regulating SG formation. Deactivating this class of enzyme has a direct correlation to lowering SG levels.

Yeast cells are a highly relevant source of information about human cells as they mimic human cell biology.

"On the surface we may be very different, but at the cellular level humans and yeast are very much the same," says Dr. Baetz. "Given that similarity, our research is of direct relevance to human cancer biology, and metabolic and neurodegenerative diseases."

The findings come at an opportune time, when a new group of drugs are being developed against these enzymes. When administered to the yeast cells, Dr. Baetz found, the new drugs were successful in lowering SG production.

Through collaboration with labs of mammalian cell biologists and cancer specialists, the team applied their findings from yeast cells to a breast cancer cell line -- and again showed the drugs had the effect of reducing SGs.

"We've discovered one way to decrease stress granule formation, plus we have therapeutics -- so we're well positioned to explore how this strategy might work on diseases," Dr. Baetz says.

The research collaboration between the three labs has led to a paper being published in PLOS Genetics. The paper highlights the research efforts of the labs of Dr. Baetz, professor Jocelyn Côté, and assistant professor Morgan Fullerton, all of uOttawa's Faculty of Medicine.

Dr. Baetz anticipates her team's work may lead to many new avenues of research, and is optimistic with regards to the fight to disarm the warriors that are cancer cells.
-end-
Media inquiries

Amélie Ferron-Craig
Media Relations Officer
University of Ottawa
Cell: 613-863-7221
aferronc@uOttawa.ca

University of Ottawa

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.